The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review

Parita Shah, Yusuke Iwata, Eric Plitman, Eric E. Brown, Fernando Caravaggio, Julia Kim, Shinichiro Nakajima, Margaret Hahn, Gary Remington, Philip Gerretsen, Ariel Graff-Guerrero

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Approximately one-third of patients with schizophrenia have treatment-resistant schizophrenia (TR-SCZ), which is a condition characterized by suboptimal response to antipsychotics other than clozapine. Importantly, treatment with clozapine—the only antipsychotic with an indication for TR-SCZ—is often delayed, which could contribute to negative outcomes. Given that the specific impact of delay in clozapine initiation is not well understood, we aimed to conduct a systematic search of the Ovid Medline® database to identify English language publications exploring the impact of delay in clozapine initiation on treatment outcomes in patients with TR-SCZ. Additionally, clinico-demographic factors associated with clozapine delay were examined. Our search identified four retrospective studies that showed an association between longer delay in clozapine initiation and poorer treatment outcomes, even after including covariates, such as age, sex, and duration of illness. In addition, we found six studies that showed an association between age and clozapine delay, but results with regard to other clinico-demographic variables were inconsistent. Overall, the available literature reveals a possible link between delay in clozapine use and poorer treatment outcomes in patients with TR-SCZ. However, given the relatively small number of studies on this clinically important topic, future research is warranted to draw more definitive conclusions.

Original languageEnglish
Pages (from-to)114-122
Number of pages9
JournalPsychiatry Research
Volume268
DOIs
Publication statusPublished - 2018 Oct 1

Fingerprint

Clozapine
Schizophrenia
Therapeutics
Antipsychotic Agents
Demography
Publications
Language
Retrospective Studies
Databases

Keywords

  • Clozapine
  • Delay
  • Outcome
  • Psychosis
  • Response
  • Schizophrenia
  • Treatment-resistant

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia : A systematic review. / Shah, Parita; Iwata, Yusuke; Plitman, Eric; Brown, Eric E.; Caravaggio, Fernando; Kim, Julia; Nakajima, Shinichiro; Hahn, Margaret; Remington, Gary; Gerretsen, Philip; Graff-Guerrero, Ariel.

In: Psychiatry Research, Vol. 268, 01.10.2018, p. 114-122.

Research output: Contribution to journalReview article

Shah, P, Iwata, Y, Plitman, E, Brown, EE, Caravaggio, F, Kim, J, Nakajima, S, Hahn, M, Remington, G, Gerretsen, P & Graff-Guerrero, A 2018, 'The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review', Psychiatry Research, vol. 268, pp. 114-122. https://doi.org/10.1016/j.psychres.2018.06.070
Shah, Parita ; Iwata, Yusuke ; Plitman, Eric ; Brown, Eric E. ; Caravaggio, Fernando ; Kim, Julia ; Nakajima, Shinichiro ; Hahn, Margaret ; Remington, Gary ; Gerretsen, Philip ; Graff-Guerrero, Ariel. / The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia : A systematic review. In: Psychiatry Research. 2018 ; Vol. 268. pp. 114-122.
@article{b8013336a1d945f4b2daf7aa244e18df,
title = "The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review",
abstract = "Approximately one-third of patients with schizophrenia have treatment-resistant schizophrenia (TR-SCZ), which is a condition characterized by suboptimal response to antipsychotics other than clozapine. Importantly, treatment with clozapine—the only antipsychotic with an indication for TR-SCZ—is often delayed, which could contribute to negative outcomes. Given that the specific impact of delay in clozapine initiation is not well understood, we aimed to conduct a systematic search of the Ovid Medline{\circledR} database to identify English language publications exploring the impact of delay in clozapine initiation on treatment outcomes in patients with TR-SCZ. Additionally, clinico-demographic factors associated with clozapine delay were examined. Our search identified four retrospective studies that showed an association between longer delay in clozapine initiation and poorer treatment outcomes, even after including covariates, such as age, sex, and duration of illness. In addition, we found six studies that showed an association between age and clozapine delay, but results with regard to other clinico-demographic variables were inconsistent. Overall, the available literature reveals a possible link between delay in clozapine use and poorer treatment outcomes in patients with TR-SCZ. However, given the relatively small number of studies on this clinically important topic, future research is warranted to draw more definitive conclusions.",
keywords = "Clozapine, Delay, Outcome, Psychosis, Response, Schizophrenia, Treatment-resistant",
author = "Parita Shah and Yusuke Iwata and Eric Plitman and Brown, {Eric E.} and Fernando Caravaggio and Julia Kim and Shinichiro Nakajima and Margaret Hahn and Gary Remington and Philip Gerretsen and Ariel Graff-Guerrero",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.psychres.2018.06.070",
language = "English",
volume = "268",
pages = "114--122",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia

T2 - A systematic review

AU - Shah, Parita

AU - Iwata, Yusuke

AU - Plitman, Eric

AU - Brown, Eric E.

AU - Caravaggio, Fernando

AU - Kim, Julia

AU - Nakajima, Shinichiro

AU - Hahn, Margaret

AU - Remington, Gary

AU - Gerretsen, Philip

AU - Graff-Guerrero, Ariel

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Approximately one-third of patients with schizophrenia have treatment-resistant schizophrenia (TR-SCZ), which is a condition characterized by suboptimal response to antipsychotics other than clozapine. Importantly, treatment with clozapine—the only antipsychotic with an indication for TR-SCZ—is often delayed, which could contribute to negative outcomes. Given that the specific impact of delay in clozapine initiation is not well understood, we aimed to conduct a systematic search of the Ovid Medline® database to identify English language publications exploring the impact of delay in clozapine initiation on treatment outcomes in patients with TR-SCZ. Additionally, clinico-demographic factors associated with clozapine delay were examined. Our search identified four retrospective studies that showed an association between longer delay in clozapine initiation and poorer treatment outcomes, even after including covariates, such as age, sex, and duration of illness. In addition, we found six studies that showed an association between age and clozapine delay, but results with regard to other clinico-demographic variables were inconsistent. Overall, the available literature reveals a possible link between delay in clozapine use and poorer treatment outcomes in patients with TR-SCZ. However, given the relatively small number of studies on this clinically important topic, future research is warranted to draw more definitive conclusions.

AB - Approximately one-third of patients with schizophrenia have treatment-resistant schizophrenia (TR-SCZ), which is a condition characterized by suboptimal response to antipsychotics other than clozapine. Importantly, treatment with clozapine—the only antipsychotic with an indication for TR-SCZ—is often delayed, which could contribute to negative outcomes. Given that the specific impact of delay in clozapine initiation is not well understood, we aimed to conduct a systematic search of the Ovid Medline® database to identify English language publications exploring the impact of delay in clozapine initiation on treatment outcomes in patients with TR-SCZ. Additionally, clinico-demographic factors associated with clozapine delay were examined. Our search identified four retrospective studies that showed an association between longer delay in clozapine initiation and poorer treatment outcomes, even after including covariates, such as age, sex, and duration of illness. In addition, we found six studies that showed an association between age and clozapine delay, but results with regard to other clinico-demographic variables were inconsistent. Overall, the available literature reveals a possible link between delay in clozapine use and poorer treatment outcomes in patients with TR-SCZ. However, given the relatively small number of studies on this clinically important topic, future research is warranted to draw more definitive conclusions.

KW - Clozapine

KW - Delay

KW - Outcome

KW - Psychosis

KW - Response

KW - Schizophrenia

KW - Treatment-resistant

UR - http://www.scopus.com/inward/record.url?scp=85049774360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049774360&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2018.06.070

DO - 10.1016/j.psychres.2018.06.070

M3 - Review article

C2 - 30015109

AN - SCOPUS:85049774360

VL - 268

SP - 114

EP - 122

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

ER -